Tenet Healthcare (NYSE:THC – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it compare to its competitors? We will compare Tenet Healthcare to related businesses based on the strength of its dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability.
Risk & Volatility
Tenet Healthcare has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Tenet Healthcare’s competitors have a beta of 0.98, meaning that their average share price is 2% less volatile than the S&P 500.
Earnings & Valuation
This table compares Tenet Healthcare and its competitors top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Tenet Healthcare | $21.31 billion | $1.41 billion | 8.43 |
| Tenet Healthcare Competitors | $21.12 billion | $288.54 million | 7.02 |
Tenet Healthcare has higher revenue and earnings than its competitors. Tenet Healthcare is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Insider & Institutional Ownership
95.4% of Tenet Healthcare shares are held by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 1.0% of Tenet Healthcare shares are held by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Tenet Healthcare and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tenet Healthcare | 13.09% | 28.22% | 6.12% |
| Tenet Healthcare Competitors | -8.02% | -140.32% | -1.38% |
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Tenet Healthcare and its competitors, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tenet Healthcare | 0 | 3 | 20 | 0 | 2.87 |
| Tenet Healthcare Competitors | 1861 | 7731 | 13356 | 821 | 2.55 |
Tenet Healthcare presently has a consensus target price of $293.48, suggesting a potential upside of 1.01%. As a group, “Healthcare Providers & Services” companies have a potential upside of 14.17%. Given Tenet Healthcare’s competitors higher probable upside, analysts plainly believe Tenet Healthcare has less favorable growth aspects than its competitors.
Summary
Tenet Healthcare beats its competitors on 10 of the 13 factors compared.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
